| 000 | 01649 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516015912.0 | ||
| 264 | 0 | _c20110707 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1432-198X | ||
| 024 | 7 |
_a10.1007/s00467-010-1734-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeroy, Valérie | |
| 245 | 0 | 0 |
_aMembranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation. _h[electronic resource] |
| 260 |
_bPediatric nephrology (Berlin, Germany) _cMar 2011 |
||
| 300 |
_a419-24 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aComplement C3 Nephritic Factor _xanalysis |
| 650 | 0 | 4 |
_aComplement Factor H _xgenetics |
| 650 | 0 | 4 |
_aComplement Factor I _xgenetics |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 |
_aGlomerulonephritis, Membranoproliferative _xdrug therapy |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFremeaux-Bacchi, Véronique | |
| 700 | 1 | _aPeuchmaur, Michel | |
| 700 | 1 | _aBaudouin, Véronique | |
| 700 | 1 | _aDeschênes, Georges | |
| 700 | 1 | _aMacher, Marie-Alice | |
| 700 | 1 | _aLoirat, Chantal | |
| 773 | 0 |
_tPediatric nephrology (Berlin, Germany) _gvol. 26 _gno. 3 _gp. 419-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00467-010-1734-4 _zAvailable from publisher's website |
| 999 |
_c20475465 _d20475465 |
||